ANDATOPICALLOTION
Approved
Dec 1981
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
3/8 — Basic
CROTAN (crotamiton) by Enterprise Therapeutics is clinical pharmacology: crotan lotion has scabicial and antipruritic actions. First approved in 1981.
Drug data last refreshed Yesterday
$0.0BPart D
Mechanism of Action
CLINICAL PHARMACOLOGY: CROTAN lotion has scabicial and antipruritic actions. The mechanisms of these actions are not known. The pharmacokinetics of crotamiton and its degree of systemic absorption following topical application have not been determined.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Worked on CROTAN at Enterprise Therapeutics? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.